Category
Blog
-
2023
-
SABCS: Pharmas show their working in HR+/HER2- breast cancer
-
Moleculin Biotech’s WP1122 Receives Fast Track Status for Glioblastoma
-
ASH: CD20 bispecific antibodies take centre stage in lymphoma
-
Mirati’s Krazati Gets Accelerated Approval for NSCLC
-
Rare Disease Moonshot launched at European Health Summit
-
Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial
-
FDA Advisors Reject Cytokinetics’ Heart Failure Candidate
-
Prime to Cover Biosimilars Alongside Humira
-
Kintara’s VAL-083 Receives Orphan Drug Status for Rare Childhood Cancer: An Exciting Breakthrough for Patients
-
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON